ClassID:

91721

C07C49/83 - CPC Classification

Classification description:

Ketones; Ketenes; Dimeric ketenes ; Ketonic chelates; Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic

Recent Application in this class:
#1
20260055046
2026-02-26

MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES

#2
20250019335
2025-01-16

NOVEL QUINIZARIN DERIVATIVE AND PREPARATION METHOD THEREOF

#3
20240368066
2024-11-07

MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES

#4
20230399282
2023-12-14

Series of skin-whitening (lightening) compounds

#5
20230365851
2023-11-16

THERMALLY CONDUCTIVE ADDITIVE, THERMALLY CONDUCTIVE COMPOSITE MATERIAL, AND WIRE HARNESS

#6
20230295070
2023-09-21

Modulators of liver receptor homologue 1 (LRH-1) and uses

#7
20230130102
2023-04-27

Na/K-ATPase LIGANDS AND USE THEREOF FOR TREATMENT OF CANCER

#8
20230015875
2023-01-19

Ion channel antagonists/blockers and uses thereof

#9
20220304958
2022-09-29

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

#10
20210188751
2021-06-24

Series of skin-whitening (lightening) compounds

#11
20210171429
2021-06-10

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#12
20210143360
2021-05-13

Display device

#13
20210109448
2021-04-15

Compound, resin, composition, resist pattern formation method, circuit pattern formation method and method for purifying resin

#14
20210047258
2021-02-18

Modulators of liver receptor homologue 1 (LRH-1) and uses

#15
20200308109
2020-10-01

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#16
20200087236
2020-03-19

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#17
20200017433
2020-01-16

Modulators of liver receptor homologue 1 (LRH-1) and uses

#18
20190276421
2019-09-12

Calixarene compound and curable composition

#19
20190233359
2019-08-01

Series of skin whitening (lightening) compounds

#20
20190177271
2019-06-13

FLUORENE COMPOUND AND PHARMACEUTICAL USE THEREOF

#21
20190023682
2019-01-24

Inhibitors of bacterial RNA polymerase: arylpropanoyl, arylpropenoyl, and arylcyclopropanecarboxyl phloroglucinols

#22
20180290960
2018-10-11

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#23
20180284615
2018-10-04

Resist underlayer film composition, patterning process, and method for forming resist underlayer film

#24
20180210114
2018-07-26

Ophthalmic lens material and ophthalmic lens of such material

#25
20180161324
2018-06-14

SHIP1 modulators and methods related thereto

#26
20170306079
2017-10-26

Phosphonium-based compound, epoxy resin composition containing same, semiconductor device manufactured using same

#27
20170275224
2017-09-28

Series of skin whitening (lightening) compounds

#28
20160257671
2016-09-08

SHIP1 modulators and methods related thereto

#29
20160194300
2016-07-07

Reagent for enhancing generation of chemical species

#30
20160083322
2016-03-24

Series of skin-whitening (lightening) compounds

#31
20160070165
2016-03-10

Reagent and composition of resist

#32
20150301448
2015-10-22

Monomer, hard mask composition comprising said monomer, and method for forming pattern using said hard mask composition

#33
20150045387
2015-02-12

Bi-Aromatic And Tri-Aromatic Compounds As NADPH Oxidase 2 (Nox2) Inhibitors

#34
20150011647
2015-01-08

Antibacterial agents: phloroglucinol derivatives

#35
20140363388
2014-12-11

Series of skin whitening (lightening) compounds

#36
20140357829
2014-12-04

Multifunctional deoxybenzoin-based monomers and resins having reduced flammability

#37
20140336258
2014-11-13

Anti-virulence compositions and methods

#38
20140221680
2014-08-07

4-acylaralkylphenols and derivatives thereof

#39
20140213682
2014-07-31

Curable inks comprising diurethane gelators

#40
20140194529
2014-07-10

USAGE OF NATURAL COMPOUND FOR TREATING INFLAMMATION AND CANCER

#41
20140155569
2014-06-05

Flame-retardant derivatives

#42
20140100342
2014-04-10

Fluorine-containing polymerizable monomer and polymer compound using same

#43
20140039182
2014-02-06

Compositions and processes of preparing and using the same

#44
20140038980
2014-02-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

#45
20130245325
2013-09-19

Sugar metabolism improving composition, and pharmaceutical preparation containing said composition

#46
20130245128
2013-09-19

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

#47
20130231405
2013-09-05

Aromatic perfluoroalkane monomer

#48
20130165663
2013-06-27

Method for preparing 5-haloalkyl-4, 5-dihydroisoxazole derivatives

#49
20130079293
2013-03-28

Neuro-protective compounds and their use

#50
20130005984
2013-01-03

11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent

#51
20120289721
2012-11-15

Preparation of alpha-hydroxyketones

#52
20120277442
2012-11-01

METHOD FOR PREPARING 5-HALOALKYL-4, 5-DIHYDROISOXAZOLE DERIVATIVES

#53
20120238781
2012-09-20

Modified naphthalene formaldehyde resin, tricyclodecane skeleton-containing naphthol compound and ester compound

#54
20120238775
2012-09-20

Modified naphthalene formaldehyde resin, tricyclodecane skeleton-containing naphthol compound and ester compound

#55
20120225890
2012-09-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

#56
20120108853
2012-05-03

Method for producing trisphenols and monoester-substituted products thereof, and 4-acylaralkylphenol derivatives

#57
20120058172
2012-03-08

PLANT EXTRACTS FOR USE IN BRAIN MODULATION

#58
20120043535
2012-02-23

Compound and organic light emitting device using the compound

#59
20120029107
2012-02-02

Oligofunctional photoinitiators

#60
20120015992
2012-01-19

Naphthalene-based inhibitors of anti-apoptotic proteins

#61
20110319483
2011-12-29

1-adamantyl chalcones for the treatment of proliferative disorders

#62
20110282025
2011-11-17

Diol, and polycarbonate resin or polyester resin

#63
20110237685
2011-09-29

Photolabile fragrance storage substances

#64
20110218226
2011-09-08

Anti-virulence compositions and methods

#65
20110212989
2011-09-01

THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ISOFLAVONES

#66
20110172239
2011-07-14

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

#67
20110172185
2011-07-14

Therapeutic drug for adult T-cell leukemia

#68
20110112282
2011-05-12

IDO INHIBITORS AND THERAPEUTIC USES THEREOF

#69
20110082176
2011-04-07

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#70
20110071178
2011-03-24

Methods and Compounds for Modulating Cannabinoid Activity

#71
20110039874
2011-02-17

MONOACYLGLYCEROL LIPASE INHIBITORS FOR MODULATION OF CANNABINOID ACTIVITY

#72
20110021613
2011-01-27

PLANTS EXTRACTS FOR USE IN BRAIN MODULATION

#73
20110009574
2011-01-13

Modified naphthalene formaldehyde resin, tricyclodecane skeleton-containing naphthol compound and ester compound

#74
20100273891
2010-10-28

ISOFLAVONE METABOLITES

#75
20100267946
2010-10-21

Prodrugs of GABA analogs, compositions and uses thereof

#76
20100267781
2010-10-21

Naphthalene-based inhibitors of anti-apoptotic proteins

#77
20100249424
2010-09-30

Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives

#78
20100249243
2010-09-30

NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY

#79
20100249075
2010-09-30

Substituted tetralins as selective estrogen receptor-β agonists

#80
20100240634
2010-09-23

Fluorene compound and pharmaceutical use thereof

#81
20100217047
2010-08-26

Process for producing 3,4′ dihydroxybenzophenone

#82
20100217046
2010-08-26

Process for producing 3,4′ diacetoxybenzophenone

#83
20100176716
2010-07-15

Compound and organic light emitting device using the compound

#84
20100137612
2010-06-03

Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound

#85
20100121082
2010-05-13

Process for preparing 2,4-dihydroxyphenyl 4-methoxybenzyl ketones

#86
20100119462
2010-05-13

UV-filter compounds

#87
20100104979
2010-04-29

Alpha-hydroxyketones

#88
20100063298
2010-03-11

11C-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent

#89
20100016347
2010-01-21

Series of skin whitening (lightening) compounds

#90
20090306016
2009-12-10

Fatty acid amide hydrolase inhibitors

#91
20090287001
2009-11-19

Process for the manufacture of hydroxylated isoflavones

#92
20090281196
2009-11-12

1-adamantyl chalcones for the treatment of proliferative disorders

#93
20090259048
2009-10-15

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#94
20090253659
2009-10-08

Cycloalkylidene compounds as modulators of estrogen receptor

#95
20090240085
2009-09-24

Method of producing diol, polydiol, secondary alcohol or diketone compound

#96
20090240020
2009-09-24

Polyether ketone, its monomer and its phenolate

#97
20090233999
2009-09-17

COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF

#98
20090233930
2009-09-17

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#99
20090209655
2009-08-20

Isoflavone metabolites

#100
20090197965
2009-08-06

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#101
20090186900
2009-07-23

COMPOUND

#102
20090162307
2009-06-25

Photolatent systems

#103
20090143374
2009-06-04

Use of compounds and compositions for the treatment of amyloid diseases

#104
20090105319
2009-04-23

Naphthalene-based inhibitors of anti-apoptotic proteins

#105
20090088444
2009-04-02

Substituted phenanthrene diketo acids and uses therefor

#106
20090075908
2009-03-19

Agent for strengthening calcium containing tissue and use thereof

#107
20090069432
2009-03-12

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#108
20090023923
2009-01-22

1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof

#109
20090018354
2009-01-15

Preparation of α-hydroxy and α-amino ketones

#110
20080312186
2008-12-18

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

#111
20080311065
2008-12-18

Anti-oxidant macromonomers and polymers and methods of making and using the same

#112
20080293718
2008-11-27

Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia

#113
20080287528
2008-11-20

Therapeutic methods and compositions involving isoflavones

#114
20080275100
2008-11-06

Propofol analogs, process for their preparation, and methods of use

#115
20080242740
2008-10-02

AROMA COMPOSITIONS OF ALKAMIDES WITH HESPERETIN AND/OR 4-HYDROXYDIHYDROCHALCONES AND SALTS THEREOF FOR ENHANCING SWEET SENSORY IMPRESSIONS

#116
20080227867
2008-09-18

Use of 4-hydroxychalcone derivatives for masking an unpleasant taste

#117
20080221220
2008-09-11

2′,4′-dichloro-biphenyl-4-yl-hydroxy-ketones and related compounds and their use as therapeutic agents

#118
20080125481
2008-05-29

ISOFLAVONE METABOLITES

#119
20080113073
2008-05-15

Hydroxydeoxybenzoins And The Use Thereof to Mask A Bitter Taste

#120
20070282136
2007-12-06

Preparation of 3-[5′-(3,4-bis(hydroxymethyl)benzyloxy)-2′-ethyl-2-propylbiphenyl-4-yl]pentan-3-ol

#121
20070240609
2007-10-18

Photoinitiators

#122
20070238902
2007-10-11

Method for Performing Aldol Reaction in Water

#123
20070213348
2007-09-13

Cycloalkylidene compounds as modulators of estrogen receptor

#124
20070197832
2007-08-23

Method of producing poly(ortho-methylphenol)

#125
20070191624
2007-08-16

Polymer incarcerated Lewis acid metal catalyst

#126
20070185217
2007-08-09

Propofol analogs, process for their preparation, and methods of use

#127
20070155839
2007-07-05

Cycloalkylidene compounds as modulators of estrogen receptor

#128
20070155813
2007-07-05

Hsp90 family protein inhibitors

#129
20070155617
2007-07-05

Functional group-selective hydrogenation catalyst and functional group-selective hydrogenation method

#130
20070135388
2007-06-14

Bicyclic cannabinoids

#131
20070129392
2007-06-07

Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders

#132
20070027112
2007-02-01

Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions

#133
20070010453
2007-01-11

Prodrugs of GABA analogs, compositions and uses thereof

#134
20060286150
2006-12-21

Therapeutic methods and compositions involving isoflavones

#135
20060270748
2006-11-30

Trifunctional photoinitiators

#136
20060264500
2006-11-23

Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents

#137
20060247264
2006-11-02

Modulators of the glucocorticoid receptor

#138
20060241323
2006-10-26

Process for the preparation of 1-phenylindan photoinitiators

#139
20060205792
2006-09-14

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#140
20060205767
2006-09-14

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#141
20060189580
2006-08-24

1-Adamantyl chalcones for the treatment of proliferative disorders

#142
20060084647
2006-04-20

Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

#143
20060041094
2006-02-23

Anti-oxidant macromonomers and polymers and methods of making and using the same

#144
20060041087
2006-02-23

Anti-oxidant macromonomers and polymers and methods of making and using the same

#145
20060004062
2006-01-05

Compounds for inhibiting insulin secretion and methods related thereto

#146
20050272957
2005-12-08

Process for preparing dibasic salts of bisphenols

#147
20050272036
2005-12-08

Ketones

#148
20050239971
2005-10-27

Difunctional photoinitiators

#149
20050222248
2005-10-06

Isoflavone metabolites

#150
20050215493
2005-09-29

Calcium-containing tissue strengthening agents and use thereof

#151
20050203315
2005-09-15

Process for converting alcohols to carbonyl compounds

#152
20050131047
2005-06-16

Therapeutic methods and compositions involving isoflavones

#153
20050065152
2005-03-24

1-Adamantyl chalcones for the treatment of proliferative disorders

#154
20050059616
2005-03-17

Therapeutic methods and compositions involving isoflavones

#155
20050049424
2005-03-03

6-Hydroxy isoflavones derivatives and medicaments involving same

#156
20050049306
2005-03-03

Non-halogenated naphthol compounds, antimicrobial compositions containing the same, and methods of using the same

#157
20050004400
2005-01-06

Method for producing deoxybenzoins

#158
20050004249
2005-01-06

Difunctional photoinitiators